Happy to be back in the blog saddle once again – it’s been a busy month with billable work, so I just know the economy is on the rebound! Can’t say the same about Novartis Pharmaceuticals Corp. Just read a Reuters article this morning announcing that a New York jury decided on $250M damages against [...]

